Some characteristics of nystatin-resistant sterol mutants of Candida albicans. 1982

M Pesti, and S Paku, and E K Novák

Various stable, auxotrophic and nystatin-resistant sterol mutants of Candida albicans were isolated after nitrosoguanidine treatment. Sterol mutants were divided into groups on the basis of the ultraviolet spectra and thin-layer chromatographic patterns of their nonsaponifiable sterol extracts. They were further characterized by their conductometrically measured nystatin-induced ion release. These sterol mutants displayed a decreased growth yield and an increased cell volume. On media containing 0.01% of the carbon sources, most of them could assimilate glycerol, alpha-methyl-D-glucoside, DL-lactic acid, L-sorbose, L-arabinose and ribitol only to a significantly reduced extent, or not at all. It is presumed that these properties result from the altered sterol composition of the plasma membrane.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009761 Nystatin Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. Fungicidin,Mycostatin,Nilstat,Nystatin A1,Nystatin A2,Nystatin A3,Nystatin G,Stamicin,Stamycin
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D013261 Sterols Steroids with a hydroxyl group at C-3 and most of the skeleton of cholestane. Additional carbon atoms may be present in the side chain. (IUPAC Steroid Nomenclature, 1987) Sterol

Related Publications

M Pesti, and S Paku, and E K Novák
January 1991, Folia microbiologica,
M Pesti, and S Paku, and E K Novák
January 1982, Journal of general microbiology,
M Pesti, and S Paku, and E K Novák
October 1971, Journal of bacteriology,
M Pesti, and S Paku, and E K Novák
June 1982, The Journal of antibiotics,
M Pesti, and S Paku, and E K Novák
October 1978, Molecular & general genetics : MGG,
M Pesti, and S Paku, and E K Novák
January 1986, Infection and immunity,
M Pesti, and S Paku, and E K Novák
November 1972, Journal of general microbiology,
M Pesti, and S Paku, and E K Novák
January 1964, Antimicrobial agents and chemotherapy,
M Pesti, and S Paku, and E K Novák
March 1959, Antibiotics & chemotherapy (Northfield, Ill.),
M Pesti, and S Paku, and E K Novák
October 1979, Antibiotiki,
Copied contents to your clipboard!